Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1,924.06 ($23.49) and traded as high as GBX 2,064 ($25.20). Hikma Pharmaceuticals shares last traded at GBX 2,062 ($25.18), with a volume of 345,386 shares trading hands.
Hikma Pharmaceuticals Stock Performance
The company has a market capitalization of £4.50 billion, a P/E ratio of 3,116.92, a P/E/G ratio of 2.38 and a beta of 0.41. The company has a current ratio of 1.66, a quick ratio of 1.27 and a debt-to-equity ratio of 55.48. The company’s fifty day moving average is GBX 1,927.95 and its 200 day moving average is GBX 1,924.78.
Hikma Pharmaceuticals Company Profile
At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.
See Also
- Five stocks we like better than Hikma Pharmaceuticals
- 3 Fintech Stocks With Good 2021 Prospects
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- How to Invest in Small Cap Stocks
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- How to buy stock: A step-by-step guide for beginners
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
